pd 98059 has been researched along with trifluoperazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Inagaki, S; Yamaguchi, M | 1 |
DeGregorio, MW; Kao, CJ; Lin, YC; Phong, B; Vang, DP; Wurz, GT | 1 |
2 other study(ies) available for pd 98059 and trifluoperazine
Article | Year |
---|---|
Regulatory role of endogenous regucalcin in the enhancement of nuclear deoxyribonuleic acid synthesis with proliferation of cloned rat hepatoma cells (H4-II-E).
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Antibodies, Monoclonal; Calcium; Calcium-Binding Proteins; Carboxylic Ester Hydrolases; Carcinoma, Hepatocellular; Cell Division; Cell Nucleus; Clone Cells; Culture Media; DNA; Enzyme Inhibitors; Flavonoids; Intracellular Signaling Peptides and Proteins; Male; Protein Kinase Inhibitors; Rats; Rats, Wistar; Staurosporine; Sulfotransferases; Trifluoperazine | 2001 |
Repurposing ospemifene for potentiating an antigen-specific immune response.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Calmodulin; Cancer Vaccines; Carcinogenesis; Chromones; Cytokines; Drug Administration Schedule; Drug Repositioning; Female; Flavonoids; Gene Expression; Humans; Immunologic Factors; Interferon-gamma; Interleukin-2; Jurkat Cells; Lung Neoplasms; Lymphocyte Activation; Membrane Glycoproteins; Mice; Mice, Transgenic; Morpholines; Mucin-1; Phosphatidylinositol 3-Kinases; RNA, Messenger; Signal Transduction; Structure-Activity Relationship; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Tamoxifen; Trifluoperazine | 2017 |